Literature DB >> 24085807

A practical approach to prescribing antidepressants.

Elizabeth Shultz1, Donald A Malone.   

Abstract

Although antidepressant drugs do not differ much in their efficacy rates, the particular characteristics of one drug may make it a better choice in a given patient. This article provides insight into the art of prescribing antidepressants in primary care, with recommendations for prescribing for patients with chronic pain, sexual dysfunction, anxiety, chronic fatigue syndrome, fibromyalgia, severe insomnia, old age, diabetes, and heart problems.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085807     DOI: 10.3949/ccjm.80a.12133

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  5 in total

Review 1.  Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes.

Authors:  A M Yohannes; G S Alexopoulos
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

2.  Conditioned task-set competition: Neural mechanisms of emotional interference in depression.

Authors:  Aleks Stolicyn; J Douglas Steele; Peggy Seriès
Journal:  Cogn Affect Behav Neurosci       Date:  2017-04       Impact factor: 3.282

Review 3.  Major depressive disorder: mechanism-based prescribing for personalized medicine.

Authors:  Philip F Saltiel; Daniel I Silvershein
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-31       Impact factor: 2.570

4.  Insomnia Increases Symptom Severity and Health Care Utilization in Patients With Fibromyalgia: A Population-based Study.

Authors:  Chun-Jen Huang; Chin-Liang Huang; Yen-Chun Fan; Ting-Yu Chen; Pei-Shan Tsai
Journal:  Clin J Pain       Date:  2019-09       Impact factor: 3.442

Review 5.  Depression and Pain: Use of Antidepressants.

Authors:  Herlinda Bonilla-Jaime; José Armando Sánchez-Salcedo; M Maetzi Estevez-Cabrera; Tania Molina-Jiménez; José Luis Cortes-Altamirano; Alfonso Alfaro-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.